Turgeon Joseph W. 4
4 · SPECTRUM PHARMACEUTICALS INC · Filed Feb 23, 2021
Insider Transaction Report
Form 4
Turgeon Joseph W.
Chief Commercial Officer
Transactions
- Award
Common Stock, $0.001 par value
2021-02-18+278,090→ 648,119 total - Sale
Common Stock, $0.001 par value
2021-02-22$3.73/sh−7,500$27,975→ 633,362 total - Sale
Common Stock, $0.001 par value
2021-02-19$3.64/sh−7,257$26,394→ 640,862 total - Award
Stock Option (Right to Buy)
2021-02-18+337,079→ 337,079 totalExercise: $3.56Exp: 2031-02-18→ Common Stock (337,079 underlying) - Award
Stock Appreciation Right
2021-02-18+792,135→ 792,135 totalExercise: $3.56Exp: 2031-02-18→ Common Stock (792,135 underlying)
Holdings
- 1,538(indirect: By 401(k))
Common Stock, $0.001 par value
Footnotes (4)
- [F1]One third of the aggregate amount of restricted shares shall vest on each of February 18, 2022, 2023 and 2024, respectively.
- [F2]All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for the purpose of satisfying tax withholding obligations in connection with restricted stock awards granted by the issuer.
- [F3]One third of the aggregate amount of option shares shall vest on each of February 18, 2022, 2023 and 2024, respectively.
- [F4]One third of the aggregate amount of stock appreciation rights shall vest on each of February 18, 2022, 2023 and 2024, respectively.